
Parkinson's disease
Pimavanserin in the Treatment of Parkinson’s Disease Psychosis: Meta-analysis and Meta-regression of Randomized Clinical Trials
by Zeeshan Mansuri, MD, MPH; Abhishek Reddy, MD; Ramu Vadukapuram, MD;
by Zeeshan Mansuri, MD, MPH; Abhishek Reddy, MD; Ramu Vadukapuram, MD;
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne
Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome
by Nina R. Schooler, PhD Dr. Schooler is Professor of
by Stacy Liechti, PhD; Gianna Capodilupo, MA; Douglas J. Opler,
by Philip D. Harvey, PhD; Anzalee Khan, PhD; and Richard
by Philip D. Harvey, PhD; Cynthia O. Siu, PhD; and
by Ariana E. Anderson, PhD; Steven P. Reise, PhD; Stephen
by Seth C. Hopkins, PhD; Ajay Ogirala, PhD, Antony Loebel,
by Søren D. Østergaard, MD, PhD; Mark G. A. Opler,